Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Int Urogynecol J Pelvic Floor Dysfunct. 2003 Oct;14(4):223-8; discussion 228. Epub 2003 Aug 26.

Sacral neuromodulation for the treatment of refractory interstitial cystitis: outcomes based on technique.

Author information

  • 1Department of Urology, William Beaumont Hospital, 3535 West 13 Mile Rd., Suite 438, Royal Oak, MI 48073, USA. kmpeters@beaumont.edu

Abstract

Patients with refractory interstitial cystitis (IC) underwent testing with sacral nerve modulation via either a traditional percutaneous approach or a staged procedure. Implanted patients were followed with scaled questionnaires and voiding diaries. Twenty-six patients who had a permanent InterStim placed had a reduction in 24-h voids of 51%. More than two-thirds of patients reported a moderate or marked improvement in urinary frequency, urgency, pelvic pain, pelvic pressure, incontinence and overall quality of life. The test to implant rate of a traditional percutaneous procedure was 52%, compared to a staged procedure of 94%. Assessing sensory response at the time of implant reduced the reoperation rate from 43% to 0%. Ninety-six per cent stated they would undergo an implant again and recommend the therapy to a friend. We concluded that sacral nerve modulation can treat refractory IC symptoms. The response to therapy and the reoperation rate are dependent on the technique used to test and implant the device.

PMID:
14530831
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk